New radiation therapy shows promise for Hard-to-Treat cancers
NCT ID NCT05867615
First seen Dec 24, 2025 · Last updated May 13, 2026 · Updated 17 times
Summary
This study tests a targeted radiation therapy (177Lu-PSMA) in 83 people with advanced or metastatic cancers that have a specific marker (PSMA) on PET scans. The treatment aims to control the disease and monitor side effects. Participants receive up to 4 cycles of the therapy, with doses adjusted based on their risk of toxicity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UO Medicina Nucleare, AUSL della Romagna
Cesena, 47521, Italy
-
UO Medicina Nucleare, IRCCS IRST
Meldola, Forlì, 47014, Italy
Conditions
Explore the condition pages connected to this study.